Sage Journals: Discover world-class research

Abstract

Aims

Nonagenarians are a fast growing segment of industrialized countries' populations. Despite a greater risk of cardiovascular disease, there are limited data about their use of preventive therapies and factors guiding decisions regarding their prescription. The aim of this study was to evaluate the prevalence of cardiovascular diseases and the patterns of use of cardiovascular treatments in subjects ≥90 years old.

Methods

Population-based, cross-sectional study, in all nonagenarians residing in the Community of Madrid (Spain). Data were obtained from their electronic clinical records in primary care.

Results

Data were available from 59,423 subjects (mean age 93.3 years, 74.2% female, 13.5% with dementia). Prevalence of cardiovascular disease was 24.1% (10.9% with coronary artery disease (CAD), 13.1% with cerebrovascular disease (CVD) and 2.7% with peripheral artery disease(PAD)). In primary prevention, the use of statins and antiplatelet agents was 21.9% and 26.7%, respectively. Of subjects with vascular disease 27.7% were receiving a combined preventive strategy (use of antithrombotics, plus statins, plus blood pressure below 140/90 mmHg). Factors favourably associated with a combined preventive strategy were: female sex (odds ratio (OR) 1.29; 95% confidence interval (CI): 1.11–1.49), being independent versus totally dependent (OR 1.94; 95% CI: 1.43–2.65), diabetes (OR 1.42; 95% CI: 1.20–1.68), and negatively, age (OR 0.87; 95% CI: 0.85–0.90), CVD versus CAD (OR 0.41; 95% CI: 0.35–0.47), PAD versus CAD (OR 0.23; 95% CI: 0.18–0.30), dementia (OR 0.61; 95% CI: 0.49–0.76) and nursing home residency (OR 0.73; 95% CI: 0.57–0.93).

Conclusion

Nonagenarians have a great burden of cardiovascular diseases and receive a great number of preventive therapies, even in primary prevention, despite their unproven efficacy at these ages.

Keywords

Aging oldest old coronary artery disease cerebrovascular disease peripheral artery disease cardiovascular preventive therapies

Get full access to this article

View all access options for this article.

References

EUROSTAT. Population projections data (base year 2015), http://ec.europa.eu/eurostat/web/population-demography-migration-projections/population-projections-data (2015, accessed 24 June 2018).

Mozaffarian

Benjamin

et al.

Heart disease and stroke statistics—2016 update. Circulation 2016; 133: e38–e360.

Rich

Chyun

Skolnick

et al.

Knowledge Gaps in Cardiovascular Care of the Older Adult Population. Circulation 2016; 133: 2103–2122.

Mahoney

Barthel

. Functional evaluation: The Barthel index. Md State Med J 1965; 14: 61–65.

Charlson

Pompei

Ales

et al.

A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis 1987; 40: 373–383.

De Burgos-Lunar

Salinero-Fort

Cárdenas-Valladolid

et al.

Validation of diabetes mellitus and hypertension diagnosis in computerized medical records in primary health care. BMC Med Res Methodol 2011; 11: 146.

Gil Montalbán

Ortiz Marrón

López-Gay

et al.

[Validity and concordance of electronic health records in primary care (AP-Madrid) for surveillance of diabetes mellitus. PREDIMERC study]. Gac Sanit 2014; 28: 393–396.

Mortensen

Falk

. Primary prevention with statins in the elderly. J Am Coll Cardiol 2018; 71: 85–94.

Cooney

Selmer

Lindman

et al.

Cardiovascular risk estimation in older persons: SCORE O.P. Eur J Prev Cardiol 2016; 23: 1093–1103.

10.

Campitelli

Maxwell

Giannakeas

et al.

The variation of statin use among nursing home residents and physicians: A cross-sectional analysis. J Am Geriatr Soc 2017; 65: 2044–2051.

11.

Chokshi

Messerli

Sutin

et al.

Appropriateness of statins in patients aged ≥80 years and comparison to other age groups. Am J Cardiol 2012; 110: 1477–1481.

12.

Johansen

Green

. Statin use in very elderly individuals, 1999–2012. JAMA Intern Med 2015; 175: 1715–1716.

13.

Gränsbo

Melander

Wallentin

et al.

Cardiovascular and cancer mortality in very elderly post-myocardial infarction patients receiving statin treatment. J Am Coll Cardiol 2010; 55: 1362–1369.

14.

Pilotto

Gallina

Panza

et al.

Relation of statin use and mortality in community-dwelling frail older patients with coronary artery disease. Am J Cardiol 2016; 118: 1624–1630.

15.

Ramos

Comas-Cufí

Martí-Lluch

et al.

Statins for primary prevention of cardiovascular events and mortality in old and very old adults with and without type 2 diabetes: Retrospective cohort study. BMJ 2018; 362: k3359.

16.

Strandberg

Kolehmainen

Vuorio

. Evaluation and treatment of older patients with hypercholesterolemia. JAMA 2014; 312: 1136–1144.

17.

Lee

DSH

Markwardt

Goeres

et al.

Statins and physical activity in older men. JAMA Intern Med 2014; 174: 1263–1270.

18.

Appelros

Farahmand

Terént

et al.

To treat or not to treat: Anticoagulants as secondary preventives to the oldest old with atrial fibrillation. Stroke 2017; 48: 1617–1623.

19.

Patrono

Morais

Baigent

et al.

Antiplatelet agents for the treatment and prevention of coronary atherothrombosis. J Am Coll Cardiol 2017; 70: 1760–1776.

20.

ASCEND Study Collaborative Group. Effects of aspirin for primary prevention in persons with diabetes mellitus. N Engl J Med 2018; 379: 1529–1539.

21.

Gaziano

Brotons

Coppolecchia

et al.

Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): A randomised, double-blind, placebo-controlled trial. Lancet 2018; 392: 1036–1046.

22.

Geraghty

Mehta

et al.

Oxford Vascular Study. Age-specific risks, severity, time course, and outcome of bleeding on long-term antiplatelet treatment after vascular events: a population-based cohort study. Lancet 2017; 390: 490–499.

23.

Elwood

. Aspirin taking in a south Wales county. Br J Cardiol 2011; 18: 238–240.

24.

Tjia

Cutrona

Peterson

et al.

Statin discontinuation in nursing home residents with advanced dementia. J Am Geriatr Soc 2014; 62: 2095–2101.

25.

Hira

Cowart

Akeroyd

et al.

Risk factor optimization and guideline-directed medical therapy in US veterans with peripheral arterial and ischemic cerebrovascular disease compared to veterans with coronary heart disease. Am J Cardiol 2016; 118: 1144–1149.

26.

Bhatt

Steg

Ohman

et al.

International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. JAMA 2006; 295: 180.

27.

Berger

Ladapo

. Underuse of prevention and lifestyle counseling in patients with peripheral artery disease. J Am Coll Cardiol 2017; 69: 2293–2300.

28.

Chrischilles

Schneider

Schroeder

et al.

Association between preadmission functional status and use and effectiveness of secondary prevention medications in elderly survivors of acute myocardial infarction. J Am Geriatr Soc 2016; 64: 526–535.

29.

Gnjidic

Bennett

Le Couteur

et al.

Ischemic heart disease, prescription of optimal medical therapy and geriatric syndromes in community-dwelling older men: A population-based study. Int J Cardiol 2015; 192: 49–55.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.62 MB

Cardiovascular disease in nonagenarians: Prevalence and utilization of preventive therapies

Abstract

Aims

Methods

Results

Conclusion

Keywords

Get full access to this article

References

Supplementary Material